Gynofem Healthcare Unlisted Shares Price
₹64▲6.67%(4.00)
About the company
Gynofem Healthcare Ltd. is a fast-growing Indian pharmaceutical company dedicated to improving women's health through specialized and innovative healthcare solutions. The company focuses on developing, manufacturing, and marketing a diverse portfolio of pharmaceutical products, with particular expertise in gynecology, fertility care, pregnancy support, and women's reproductive health. Its products are designed to address the unique healthcare needs of women at every stage of motherhood—from planning a pregnancy and conception to prenatal care, childbirth, and postnatal recovery.
Gynofem's product range supports women who are trying to conceive naturally as well as those requiring medical assistance due to fertility-related conditions. The company also offers nutritional and therapeutic solutions that help promote a healthy pregnancy, support fetal development, and aid mothers in recovering after childbirth. By focusing on quality, safety, and clinical effectiveness, Gynofem aims to make specialized women's healthcare more accessible and reliable.
Fundamentals
Valuation
| Metric | Value |
|---|---|
| 52 week high | ₹116 |
| 52 week low | ₹48 |
| P/B ratio | 0 |
| Debt to equity | N/A |
| ROE (%) | N/A |
| Book value | N/A |
| Face value | — |
52 week high
52 week low
| Metric | Value |
|---|---|
| 52 week high | ₹116 |
| 52 week low | ₹48 |
Registry
| Metric | Value |
|---|---|
| ISIN number | INE0NLL01017 |
Leadership
Frequently asked questions
Common questions on Gynofem Healthcare Unlisted Shares Price—tap a row to read the answer.
Q.1What does Gynofem Healthcare Ltd. do?
Gynofem Healthcare Ltd. is an Indian pharmaceutical company focused on women's healthcare. It develops and markets a range of products related to gynecology, fertility care, pregnancy support, maternal nutrition, and postnatal recovery. The company primarily serves the domestic market and aims to make specialized healthcare products accessible across both urban and rural India.
Q.2How can I buy Gynofem Healthcare Unlisted Shares?
You can purchase Gynofem Healthcare Unlisted Shares through an off-market transaction from an existing shareholder or a registered intermediary dealing in unlisted securities. Once the required documentation, payment, and verification are completed, the shares are transferred electronically to your Demat account.
Q.3How is the Gynofem Healthcare Unlisted Share Price determined?
Unlike listed stocks, unlisted shares are not traded on stock exchanges. Their price is generally determined by factors such as the company's financial performance, business growth, market demand, recent private transactions, industry outlook, and overall investor interest. Since there is no live market price, valuations may differ between transactions.
Q.4Is Gynofem Healthcare a good long-term investment?
The suitability of any investment depends on your financial goals and risk tolerance. Before investing in Gynofem Healthcare Unlisted Shares, consider the company's business model, financial performance, management quality, industry outlook, profitability, and future growth potential. Conducting thorough research helps you make a more informed investment decision.
Q.5Can I sell Gynofem Healthcare Unlisted Shares whenever I want?
Yes, unlisted shares can generally be sold through private off-market transactions. However, unlike listed stocks, selling depends on finding a willing buyer. As a result, the time required to complete a transaction may vary based on market demand and liquidity.
Q.6Does Gynofem Healthcare have plans for an IPO?
Any future IPO plans depend entirely on the company's strategic decisions and regulatory approvals. Investors should rely on official company announcements for the latest information rather than market speculation.
Unlisted Trending shares
High-demand unlisted opportunities currently available for trade.
MARKET INSIGHTS & UPDATES
Read the latest updates, investment ideas, and market insights designed to help investors better understand unlisted and pre-IPO opportunities.

NSE IPO 2026: Dates, Allotment & Listing Details
The much-awaited NSE IPO is set to make a major market debut in September 2026. As per the announced schedule, the IPO will open on 21 September and close on 23 September 2026, followed by share allotment on 24 September and listing on 28 September 2026. With strong investor interest and NSE’s position as one of India’s leading market institutions, the IPO is expected to attract significant attention. Here’s a quick look at the NSE IPO 2026 timeline and important dates investors should know.

Upcoming IPOs in 2026: NSE, Rentomojo, Manipal & Pranav Guide
Four major 2026 IPOs: NSE, Manipal Payment, Rentomojo, Pranav Constructions. For pre-IPO investors, these mark critical transitions from private to public valuations. Conduct due diligence before investing.

Purple Style Labs: From Unlisted Shares to IPO - A Price Journey Worth Noticing
Purple Style Labs is making headlines as it moves from the unlisted market towards its IPO. With its unlisted shares trading around ₹500–₹525 and an IPO price band of ₹546–₹575, the price journey offers an interesting look at how private-market and IPO valuations can differ.

Muthoot FinCorp Unlisted Shares: Q1FY27 Profit Surges to ₹705 Cr | Fundamentals & IPO
Muthoot FinCorp's Q1FY27 profit surged to ₹705.48 crore as the company moves toward a proposed ₹3,000-crore IPO. Here's a look at its financial performance, valuation metrics, asset quality and key fundamentals.

From Debt to Debt-Free: How API Holdings Used Thyrocare to Reshape Its Balance Sheet
API Holdings has repaid ₹1,050 crore of debt by monetising a 9.90% stake in Thyrocare while retaining 51.02% control. Here's how the move reshapes its balance sheet and what it means going forward.

Pre IPO Shares in India: Price, How to Buy & Complete Guide
Learn what Pre IPO Shares are, how their prices are determined, how to buy them in India, and what investors should check before investing in unlisted companies.
